Diabetes, Vol 49, Issue 6 953-960, Copyright © 2000 by American Diabetes Association

ARTICLES

Sulfonylurea receptor 1 and Kir6.2 expression in the novel human insulin-secreting cell line NES2Y

WM Macfarlane, RE O'Brien, PD Barnes, RM Shepherd, KE Cosgrove, KJ Lindley, A Aynsley-Green, RF James, K Docherty and MJ Dunne
School of Biochemistry and Genetics, University of Newcastle upon Tyne, UK.

NES2Y is a proliferating human insulin-secreting cell line that we have derived from a patient with persistent hyperinsulinemic hypoglycemia of infancy. This disease is characterized by unregulated insulin release despite profound hypoglycemia. NES2Y cells, like beta-cells isolated from the patient of origin, lack functional ATP-sensitive potassium channels (KATP) and also carry a defect in the insulin gene-regulatory transcription factor PDX1. Here, we report that the NES2Y beta-cells that are transfected with the genes encoding the components of KATP channels in beta-cells, sulfonylurea receptor (SUR) 1 and Kir6.2, have operational KATP channels and show normal intracellular Ca2+ and secretory responses to glucose. However, these cells, designated NESK beta-cells, have impaired insulin gene transcription responses to glucose. NES2Y beta-cells that are transfected with either Kir6.2 or SUR1 alone do not express functional KATP channels and have impaired intracellular free Ca2+ concentration-signaling responses to depolarization-dependent beta-cell agonists. These findings document that in NES2Y beta-cells, coexpression of both subunits is critically required for fully operational KATP channels and KATP channel-dependent signaling events. This article further characterizes the properties of the novel human beta-cell line, NES2Y, and documents the usefulness of these cells in diabetes-related research.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				W. Gartner, G. Vila, T. Daneva, A. Nabokikh, F. Koc-Saral, A. Ilhan, O. Majdic, A. Luger, and L. Wagner New functional aspects of the neuroendocrine marker secretagogin based on the characterization of its rat homolog Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E347 - E354. [Abstract] [Full Text] [PDF]

				S. G. Straub, K. E. Cosgrove, C. Ämmälä, R. M. Shepherd, R. E. O'Brien, P. D. Barnes, N.'a. Kuchinski, J. C. Chapman, M. Schaeppi, B. Glaser, et al. Hyperinsulinism of Infancy: The Regulated Release of Insulin by KATP Channel--Independent Pathways Diabetes, February 1, 2001; 50(2): 329 - 339. [Abstract] [Full Text]

				W. Moritz, C. A. Leech, J. Ferrer, and J. F. Habener Regulated Expression of Adenosine Triphosphate-Sensitive Potassium Channel Subunits in Pancreatic {beta}-Cells Endocrinology, January 1, 2001; 142(1): 129 - 138. [Abstract] [Full Text] [PDF]

				C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities Pharmacol. Rev., December 1, 2000; 52(4): 557 - 594. [Abstract] [Full Text] [PDF]